EXECUTIVE BOARDNotice no.: 5/2007
17 April 2007
Patent dispute over SPEZYME® ETHYL settled as expected
A settlement has been reached on the level of reasonable legal costs, incurred
prejudgment interest etc. in the patent dispute over SPEZYME® ETHYL (see Stock
Exchange Notice no. 2/2007 of 19 February 2007). Accordingly, Novozymes A/S
will receive a total payment of USD 15.3 million inclusive of patent
infringement damages of USD 8.2 million.
Concurrently, the parties have concluded an agreement on reciprocal waiving of
the right to appeal the decision of the court of first instance and have agreed
not to publish any details of the settlement.
The total amount, which is due for immediate payment, will not have an impact
on earnings expectations for 2006/07 as provision was previously made for the
amount.
Danisco releases its results for the financial year 2006/07 on 20 June 2007.
Yours faithfully
Tom Knutzen
CEO
For further information, please contact:
Investor Relations, Danisco A/S, tel. +45 3266 2912
Media Relations, Danisco A/S, tel. +45 3266 2913
